ALung Technologies raises $10.8 million

Artificial lung-like device developer ALung Technologies raised $10.8 million in a new round of debt financing according to an SEC filing posted this week. The money already raised in the round comes from 63 unnamed investors, according to the SEC filing. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted into the jugular or femoral vein. The company said that the remaining $1.2 million it looks to raise includes notes that are to be issued to Equinox Securities Melvin Pirchesky as part of a commission, according to the filing. Early last month, ALung Technologies said its Hemolung RAS extracorporeal carbon dioxide removal device was selected for use in the world’s 1st pivotal trial of ECCO2R technology used to treat patients with acute respiratory failure. The U.K.’s National Institute for Health Research will supply $3.1 million (GBP £2.1 million) in funding for the 1,120 patient Rest trial, which looks to examine the effect of protective ventilation with veno-venous lung assist devices during respiratory failure. The trial will be jointly led by Queen’s University and Belfast Health and Social Services Trust, the company said. The post ALung Technologies raises $10.8 million appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Blog Source Type: news

Related Links:

Conditions:   Lung Diseases;   Lung Neoplasm Intervention:   Procedure: Endobronchial Ultrasound Sponsors:   St. Joseph's Healthcare Hamilton;   NeuralSeg Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Lung Transplantation;   Chronic Lung Allograft Dysfunction;   Rejection Lung Transplant Intervention:   Other: Early detection of CLAD by Lung Clearance Index (LCI) Sponsor:   University of Zurich Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Lung Diseases;   Lung Neoplasm Intervention:   Procedure: Endobronchial Ultrasound Sponsors:   St. Joseph's Healthcare Hamilton;   NeuralSeg Not yet recruiting
Source: - Category: Research Source Type: clinical trials
ConclusionCLAD, especially RAS, appears to develop later after LDLLT than after CLT and seems to have a lower impact on the overall survival after LDLLT than that after CLT.
Source: Surgery Today - Category: Surgery Source Type: research
The implementation of effective prevention strategies has significantly reduced the incidence of cytomegalovirus (CMV) pneumonia after allogeneic hematopoietic stem transplantation (allo-HSCT)1; nevertheless, this clinical entity persists as a major clinical problem owing to poor survival, despite timely initiation of targeted antiviral therapy.1,2 Currently, diagnosis of CMV pneumonia still remains a challenge. Proven CMV pneumonia can only be diagnosed using virological, histopathological or immunochemistry methods on biopsied lung tissue1; this specimen type, however, is rarely obtained due to potential life-threatening complications.
Source: Journal of Infection - Category: Infectious Diseases Authors: Source Type: research
rin Nicolas Glaichenhaus Joel Guigay Marius Ilié Bernard Mari Charles-Hugo Marquette Véronique Paquis-Flucklinger Frédéric Prate Pierre Saintigny Barbara Seitz-Polsky Taycir Skhiri Ellen Van Obberghen-Schilling Emmanuel Van Obberghen Laurent Yvan-Charvet It is generally accepted that carcinogenesis and aging are two biological processes, which are known to be associated. Notably, the frequency of certain cancers (including lung cancer), increases significantly with the age of patients and there is now a wealth of data showing that multiple mechanisms leading to mali...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Perspective Source Type: research
PMID: 30785776 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - Category: Respiratory Medicine Authors: Tags: Am J Respir Crit Care Med Source Type: research
Cystic fibrosis liver disease (CFLD) remains the third leading cause of death in patients with cystic fibrosis. Although most patients with CFLD present in childhood, recent studies suggest a second wave of liver disease in adulthood. There are no clear guidelines for diagnosing CFLD. Treatment options for CFLD remain limited, and while UDCA is widely used, its long-term benefit is unclear. Those who develop hepatic decompensation or uncontrolled variceal bleeding may benefit from liver transplant, either alone, or in combination with lung transplant.
Source: Clinics in Liver Disease - Category: Gastroenterology Authors: Source Type: research
CONCLUSION: Our results suggest that ESS is associated with a reduction in the frequency of antibiotic utilization for respiratory tract infections in lung transplant recipients with CF. A prospective study is needed to investigate these relationships further. PMID: 30781973 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Tags: Am J Rhinol Allergy Source Type: research
How could a country keep around 1.4 billion people healthy when the system struggles with corruption, lack of resources and an aging population? China, the emerging giant with a strong central leadership fostering technology and innovation, places its bets on artificial intelligence, telemedicine, cloud-based hospitals, and WeChat. While that could sound like an ultimate technological paradise, the question is, what are they going to do with the vast amount of data or to what interests are they going to leverage their state of the art A.I. systems? Generally, how will we speak about digital health in China: a healthcare dy...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Artificial Intelligence in Medicine Bioethics Future of Medicine Medical Professionals Patients Policy Makers AI chatbot china digital digital health Healthcare Innovation smartphone technology telehealth telemedicine Source Type: blogs
More News: Blogging | Funding | Health | Lung Transplant | Medical Devices | National Institute for Health Research (NIHR) | Respiratory Medicine